ArticleScientific reports2026
A multi-task learning approach combining regression and classification tasks for joint feature selection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating differential privacy into federated multi-task learning algorithms inBioinformatics advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multi-task learning (MTL) is a learning paradigm that enables the simultaneous training of multiple communicating algorithms, and has been widely applied in the biomedical analysis for shared biomarker identification. Although MTL has successfully supported either regression or classification tasks, incorporating mixed types of tasks into a unified MTL framework remains challenging, especially in biomedicine, where it can lead to biased biomarker identification. To address this issue, we propose an improved method of multi-task learning, MTLComb, which balances the weights of regression and classification tasks to promote unbiased biomarker identification. We demonstrate the algorithmic efficiency and clinical utility of MTLComb through analyses on both simulated data and actual biomedical studies pertaining to sepsis and schizophrenia. The code is available at https://github.com/transbioZI/MTLComb .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.